Archer Research

Archer Research

Ghent, Belgium· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $4.8M

Overview

Archer Research is a specialized, full-service CRO providing comprehensive clinical research and regulatory support exclusively for medical device companies. Operating from Ghent, Belgium, it leverages its European base and a US partnership to help clients achieve compliance with the EU MDR and FDA regulations, facilitating market access on both continents. The company emphasizes a personalized, high-touch approach, positioning itself as an integrated extension of its clients' teams to manage clinical evidence throughout a device's lifecycle. Its core value proposition is future-proofing clinical evidence for medical devices in a stringent and evolving regulatory environment.

Drug DiscoveryContract Research

Technology Platform

Integrated service platform for medical device clinical research, specializing in MDR/IVDR compliance, full lifecycle clinical evidence generation, and regulatory strategy, operating under ISO 14155:2020, ISO 20916, and other quality standards.

Funding History

2
Total raised:$4.8M
Seed$4M
Grant$800K

Opportunities

The stringent and ongoing requirements of the EU Medical Device Regulation (MDR) create sustained, high demand for specialized clinical evidence services.
The company's dual EU-US capability through its partnership allows it to capture clients seeking concurrent regulatory pathways, expanding its addressable market.

Risk Factors

Heavy reliance on the medical device sector and EU MDR regulatory stringency creates concentration risk.
The CRO market is intensely competitive, requiring constant differentiation.
Operational success is entirely dependent on the quality and retention of specialized staff in a competitive labor market.

Competitive Landscape

Archer competes in the medical device-focused segment of the broader CRO market, facing competition from large, diversified CROs with device divisions (e.g., ICON, Medpace) and other niche, device-specialized CROs. Its key differentiators are its exclusive device focus, personalized service model, European base, and strategic US partnership for transatlantic support.